Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Mar 8, 2016, after the close
10-K filed Mar 8, 2016, 68 days after period end · 0001558370-16-003898
Q4 2015 · 10-K
Revenue—
Net income—
EPS Diluted-$0.14-$0.14N/M vs Q4 2014 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q3 2015
Operating Incomederived-$12,747,000N/M Operating Cash Flowderived-$13,797,000N/M Free Cash Flowderived-$13,931,000N/M ended Dec 31, 2015 · filed Mar 8, 2016 · 68 d after period end
+4.0% from the close of Mar 8, 2016 to the close of Mar 9, 2016, the first after the release.
after the close$2.27$2.36 Feb 8Mar 8Apr 5